Anti-thymocyte Globulin as an Adjunct to Treatment of Fulminant Lymphocytic Myocarditis

Journal of Heart and Lung Transplantation

Volumn 28, Issue 11, 2009, Pages 1211-1214

  Manins, Vance ^a   Parle, Niki ^a   Dembo, Lorry ^a   O'Driscoll, Gerry ^a,b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF NOTRE DAME   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; LEVOSIMENDAN; METHYLPREDNISOLONE; MILRINONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; THYMOCYTE ANTIBODY;

ADULT; AORTA BALLOON; AORTA VALVE REGURGITATION; ARTICLE; CARDIOGENIC SHOCK; CD3+ T LYMPHOCYTE; CLINICAL ARTICLE; DRUG DOSE REDUCTION; ECHOCARDIOGRAPHY; FEMALE; FULMINANT LYMPHOCYTIC MYOCARDITIS; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART MUSCLE BIOPSY; HEART PACING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOTENSION; LUNG EDEMA; MALE; MYOCARDITIS; PRIORITY JOURNAL; SEROLOGY;

ADULT; ANTILYMPHOCYTE SERUM; ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTES; MALE; MIDDLE AGED; MYOCARDITIS;

EID: 70350230100     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.07.013     Document Type: Article

References (14)

1. Fenoglio J., Ursell P., Kellogg C., et al. Diagnosis and classification of myocarditis by endomyocardial biopsy. N Engl J Med 308 (1983) 12-18
2. D'Ambrosio A., Patti G., Manzoli A., et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 85 (2001) 499-504
3. McCarthy III R., Boehmer J., Hruban R., et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342 (2000) 690-695
4. Schwimmbeck P., Badorff C., Rohn G., et al. The role of sensitized T-cells in myocarditis and dilated cardiomyopathy. Int J Cardiol 54 (1996) 117-125
5. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 99 (1999) 1091-1100
6. Acker M. Mechanical circulatory support for patients with acute-fulminant myocarditis. Ann Thorac Surg 71 suppl (2001) S73-S76
7. Simon A., Kormos R., Murali S., et al. Myocardial recovery using ventricular assist devices-prevalence, clinical characteristics, and outcomes. Circulation 112 suppl (2005) I-32-I-36
8. Goland S., Czer L., Siegel R., et al. Intravenous immunoglobulin treatment for acute fulminant inflammatory cardiomyopathy: series of six patients and review of literature. Can J Cardiol 24 (2008) 571-574
9. Chau E., Chow W., Chiu C., et al. Treatment and outcome of biopsy-proven fulminant myocarditis in adults. Int J Cardiol 28 (2006) 405-406
10. Seko Y., Tsuchimochi H., Nakamura T., et al. Expression of major histocompatibility complex class 1 antigen in murine ventricular myocytes infected with coxsackievirus B3. Circ Res 67 (1990) 360-367
11. Jett G., Miller A., Savino D., et al. Reversal of acute fulminant lymphocytic myocarditis with combined technology of OKT3 monoclonal antibody and mechanical circulatory support. J Heart Lung Transplant 11 (1992) 733-738
12. Ankersmit H., Ullrich R., Moser B., et al. Recovery from giant cell myocarditis with ECMO support and utilisation of polyclonal antithymocyte globulin: a case report. Thorac Cardiovasc Surg 54 (2006) 278-280
13. Pinderski L., Fonarow G., Hamilton M., et al. Giant cell myocarditis in a young man responsive to T-lymphocyte cytolytic therapy. J Heart Lung Transplant 21 (2002) 818-821
14. Menghini V., Savcenko V., Olson L., et al. Combined immunosuppression for the treatment of idiopathic giant cell myocarditis. Mayo Clin Proc 74 (1999) 1221-1226